| Section | Name |
| 02.05.05.03 | Aliskiren |
| 13.05.03 | Baricitinib Olumiant® |
| 10.01.03 | Baricitinib |
| 13.02.01.01 | Bath and shower preparations for dry and pruritic skin conditions |
| 04.07.01 | Co-proxamol |
| 04.03.01 | Dosulepin |
| 02.05.04 | Doxazosin MR |
| 07.04.01 | Doxazosin MR |
| 13.05.03 | Dupilumab Dupixent® |
| 03.09.01 | Gefapixant |
| 09.04 | Glucosamine and Chondroitin |
| 08.01.05 | Idecabtagene vicleucel |
| 08.01.05 | Lisocabtagene maraleucel |
| 09.04 | Lutein and Antioxidants |
| 08.01.01 | Melphalan flufenamide |
| 02.12 | Omega-3 Fatty Acid Compounds (excluding icosapent ethyl [Vazkepa®]) |
| 08.01.05 | Pembrolizumab Keytruda® |
| 10.02.01 | Ravulizumab Ultomiris® |
| 10.03.02 | Rubefacients (excluding topical NSAIDs) |
| 10.02.01 | Satralizumab Enspryng® |
| 09.08.01 | Sebelipase alfa Kanuma® |
| 18.08.03 | Silk garments |
| 08.02.02 | Sirolimus Hyftor® |
| 08.01.05 | Tisagenlecleucel |
| 05.03.06 | Tixagevimab plus cilgavimab |
| 08.01.05 | Trastuzumab deruxtecan Enhertu® |
| 08.01.01 | Treosulfan Trecondi® |
| 04.03.01 | Trimipramine |
| 08.01.05 | Zanubrutinib Brukinsa® |